Advanced searches left 3/3

Genital Warts - Crossref

Summarized by Plex Scholar
Last Updated: 24 June 2022

* If you want to update the article please login/register

Human Papillomavirus in Thai Women and Men with Anogenital Warts

However, the number of HPV genotypes in patients with genital warts in Thailand is uncertain. The aim of this research was to look at HPV-associated anogenital warts in the Thai population and determine whether genotypes present in the bivalent and quadrival HPV vaccine are identical. Methods: This review included 206 anogenital swab samples from patients with anogenital warts. The bulk of HPV genotypes tested in this study were low-risk genotypes HPV6 and HPV11, which were the most common disease found in genital warts.

Source link: https://doi.org/10.1159/000497351


Topical and Systemic Retinoids for the Treatment of Genital Warts: A Systematic Review and Meta-Analysis

The warts can regress spontaneously or follow a regular medical program. There are no studies based on their use for genital warts. Objective: To review the published data on the efficacy and safety of retinoids for the treatment of genital warts. Methods: A systematic review and meta-analysis of all journals reviewing topical or systemic retinoids for the treatment of genital warts was carried out. The results: Six journals were reviewed, three randomized controlled trials, and three prospective cohort studies were conducted, with a total of 141 patients with genital warts treated exclusively with retinoids. CR rates for systemic etretinate and 56% for isotretinoin were 100% and 56% for isotretinoin. The most common side effect of topical agents was irritation dermatitis and that of systemic agents mucocutaneous disorders. Conclusions: According to current results, topical retinoids, systemic retinoids, which are not, are a safe and efficient treatment for genital warts.

Source link: https://doi.org/10.1159/000511398


Genital warts: a study of patient anxiety and information needs

One of the most common infections in genitourinary medicine clinics is infection with genital warts. The patients' knowledge and anxiety regarding their diagnosis was determined by a research of 50 women with a first-time diagnosis of genital warts. Patients in the eight case lack basic information about the way of transmission of genital warts and the use of condoms for prophylactic use.

Source link: https://doi.org/10.12968/bjon.1996.5.3.174


Evaluation of podophyllin and Trichloroacetic acid for the treatment of genital warts in Iraqi female patients

Human paillomavirus infections are the most common sexually transmitted viral infections. Objective: To determine the efficacy of podophyllin, a trichloracetic acid, in the treatment of genital warts and the side effects of them. A total of sixty patients with genital warts were randomly selected, 30 in each group, in the Department of Dermatology, medical city, for a period of 11 months from January 2009 to December 2009, with 35 percent podophyllin in the tincture of benzoin or 50% TCA. Forty-eight patients were followed up for three months.

Source link: https://doi.org/10.47723/kcmj.v18i1.276


Declines in Anogenital Warts Among Age Groups Most Likely to Be Impacted by Human Papillomavirus Vaccination, United States, 2006–2014

We estimated annual AGW prevalence between 2006 and 2014 using health care information from our U. S. private health insurance enrollees aged 15 to 39 years. During 2008 to 2014, prevalence decreased among females aged 15 to 19 years, as well as women aged 25 to 29, which were 25 to 29 years old. We observed AGW declines among females in the age groups most likely to be affected by human papillomavirus vaccination, as well as decreases in men aged 20 to 24 years.

Source link: https://doi.org/10.2105/ajph.2017.304119


Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2003–2010: Potential Impact of Human Papillomavirus Vaccination

In a large U. S. cohort with private insurance, we estimated anogenital wart prevalence from 2003 to 2010 in order to find potential decreases among people most likely to be affected by human papillomavirus vaccinations. Within a year, we restricted health insurance claims to people aged 10 to 39 years with continuous insurance. Anogenital wart diagnosis was derived from a diagnosis of condyloma acuminata, or a less specific viral wart diagnosis or genital wart treatment, as well as either a benign anogenital neoplasm formation or removal of a noncervical anogenital lesion, can be obtained by a noncervical anogenital lesion. These results show decreases in anogenital warts among women aged 15 to 24 years, the age group most likely to be affected by the introduction of the HPV vaccine.

Source link: https://doi.org/10.2105/ajph.2012.301182


Sexual function and sexual quality of life in men with genital warts: a cross-sectional study

Abstract Background The first sexually transmitted disease, human papillomavirus, is the most common sexually transmitted disease, usually passing from one individual to another after the first sexual activity. Patients could have a variety of health problems as a result of this virus and the occurrence of genital warts. This investigation was conducted to determine the sexual function and sexual quality of life in men with GWs. Methods This cross-sectional research was conducted from September 2019 to March 2020, with a sample size of 105 men with GWs in the dermatology clinic of Shahid Faghihy Hospital in Shiraz University of Medical Sciences, Iran. Results The mean score for overall sexual function in men was 48. 50 out of a total of 8. 89. Conclusions: GWs impacted men'u2019s erection more than the other sexual function domains. Men with GWs have a dramatic effect on their SQOL and ED because of faulty SQOL and ED.

Source link: https://doi.org/10.1186/s12978-022-01403-z


Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada

BACKGROUND The incidence of anogenital warts has decreased since the introduction of the quadrivalent human papillomavirus vaccine in several countries. The interpretation of the qHPV vaccination strategy is influenced by how comparing AGW incidence rates with different outcomes. For both outcomes, the 1997-1998 birth cohort and the older 1995-1996 birth cohort were then used incidence rate ratios to compare, respectively. Since the introduction of the female-only qHPV vaccination scheme, AGW incidence in Manitoba dropped 72% among 16-year-old girls and 51% among boys. Trends in AGW-related prescriptions were different from AGW diagnoses, AGW diagnoses included, as these prescriptions peaked shortly after the introduction of the publicly funded qHPV vaccine program. For 16-24 year-old girls, Chlamydia and gonorrhea incidence rates dropped 12% and 16%, respectively. Conclusions The publicly funded school-based qHPV vaccine program in Manitoba reduced AGW infections in Manitoba by three-quarters in young females.

Source link: https://doi.org/10.1371/journal.pone.0267646

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions